SEATTLE--(BUSINESS WIRE)--Feb. 28, 2023-- Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, will participate in two upcoming healthcare conferences.

• Tuesday, March 7^th at 10:30am ET/7:30am PT, the Company will take part in a corporate panel discussion on autoimmune and inflammatory diseases and host investor meetings at the 46^th Annual Cowen Healthcare Conference
• Tuesday, March 14^th at 3:20pm ET/12:20 pm PT, the Company will participate in a fireside chat and host investor meetings at the 33^rd Annual Oppenheimer Healthcare Conference.

Live webcasts of the presentations will be available in the investor relations section of the Company’s website at https://ir.alpineimmunesciences.com/events and replays will be available on the Company's website for 90 days following the live events.

About Alpine Immune Sciences

Alpine Immune Sciences is committed to leading a new wave of immune therapeutics. With world-class research and development capabilities, a highly productive scientific platform, and a proven management team, Alpine is seeking to create first- or best-in-class multifunctional immunotherapies via unique protein engineering technologies to improve patients’ lives. Alpine has entered into strategic collaborations with leading global biopharmaceutical companies and has a diverse pipeline of clinical and preclinical candidates in development. For more information, visit www.alpineimmunesciences.com and follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230228006417/en/

Media and Investor Contact:
Temre Johnson
Alpine Immune Sciences, Inc.
[email protected]

Source: Alpine Immune Sciences, Inc.